Aerie Pharmaceuticals Inc financial data

Location
4301 Emperor Boulevard, Suite 400, Durham, NC
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2022 - Nov 4, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 261 % -7.06%
Quick Ratio 35.4 % +29.1%
Debt-to-equity -454 % +71.4%
Return On Equity 32.6 % -95.2%
Return On Assets -9.21 % +79.6%
Operating Margin -12.5 % +90.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.4M shares +4.35%
Common Stock, Shares, Outstanding 49.4M shares +4.69%
Common Stock, Value, Issued 49K USD +4.26%
Weighted Average Number of Shares Outstanding, Basic 47.8M shares +3.19%
Weighted Average Number of Shares Outstanding, Diluted 47.8M shares +3.19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 214M USD +105%
Research and Development Expense 87.6M USD +18.8%
Costs and Expenses 241M USD +1.18%
Operating Income (Loss) -26.7M USD +80%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -35.2M USD +78.1%
Income Tax Expense (Benefit) 1.32M USD -75.5%
Net Income (Loss) Attributable to Parent -36.6M USD +78%
Earnings Per Share, Basic -0.73 USD/shares +34.9%
Earnings Per Share, Diluted -0.73 USD/shares +34.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 54.1M USD -12.5%
Cash, Cash Equivalents, and Short-term Investments 172M USD +2.9%
Accounts Receivable, after Allowance for Credit Loss, Current 73.9M USD +14.4%
Inventory, Net 46.8M USD +55.6%
Assets, Current 303M USD +9.73%
Property, Plant and Equipment, Net 50.3M USD -2.68%
Operating Lease, Right-of-Use Asset 20.8M USD -10.4%
Other Assets, Noncurrent 1.72M USD +72.4%
Assets 376M USD +6.76%
Accounts Payable, Current 9.06M USD +12.2%
Employee-related Liabilities, Current 11.7M USD -19.5%
Accrued Liabilities, Current 119M USD +12.5%
Contract with Customer, Liability, Current 85.5M USD +7.15%
Liabilities, Current 133M USD +12.9%
Contract with Customer, Liability, Noncurrent 70.9M USD +32%
Operating Lease, Liability, Noncurrent 19.5M USD -13.2%
Other Liabilities, Noncurrent 3.25M USD +49.9%
Liabilities 540M USD +27.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -803K USD -1261%
Retained Earnings (Accumulated Deficit) -1.19B USD +0.95%
Stockholders' Equity Attributable to Parent -164M USD -125%
Liabilities and Equity 376M USD +6.76%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 61.9M USD
Net Cash Provided by (Used in) Financing Activities -357K USD +67.6%
Net Cash Provided by (Used in) Investing Activities -42.3M USD -1955%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 49.4M shares +4.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 19.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 54.1M USD -12.5%
Depreciation 1.6M USD +7.01%
Payments to Acquire Property, Plant, and Equipment 1.6M USD +107%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37.3M USD +77.6%
Property, Plant and Equipment, Gross 78M USD +6.93%
Operating Lease, Liability, Current 4.87M USD +23.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Additional Paid in Capital 1.02B USD -9.03%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 18.4M USD -44.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%